Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers
Acta Cytologica · 27.01.2025 · 69 (2) · 191-201
DOI: 10.1159/000543739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cytologica, online erschienen am 27.01.2025. Verfasst von Elisabetta Maffei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University Hospital of Salerno, Salerno, Italy. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Biomarkers, Tumor, Cytodiagnosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Introduction
Around 85% of non-small cell lung cancers (NSCLCs) are diagnosed at an advanced stage (IIIB to IV), where therapeutic options depend on molecular analysis. However, diagnostic material for molecular testing is often represented by cytological samples which are generally scarce and span a wide range of preparation types. Thus, the primary objective is to efficiently manage materials for molecular profiling. This study aims to evaluate the suitability of different cytological samples to assess morphological and molecular characteristics of advanced NSCLC.
Methods
Sixty-seven cytological samples obtained from patients with advanced NSCLC were utilized. The series encompassed different procedure types (fine-needle aspiration cytology, transbronchial needle aspiration, effusions) processed by cell blocks in 54% (n = 36), direct smears in 33% (n = 22), and liquid-based cytology (LBC) in 13% (n = 9). Cytological diagnoses were routinely performed, and molecular analysis was conducted using next-generation sequencing (NGS) and real-time polymerase chain reaction (RT-PCR) methods.
Results
Adequate quantity and quality of nucleic acids were obtained from all the samples, allowing molecular profiling. Combined NGS and RT-PCR analysis showed wild-type profiles in 62.7% (n = 42) and mutated profiles in 37.3% (n = 25) of the samples. Kirsten Rat Sarcoma Virus (KRAS) mutations were identified in 19.5% (n = 13) of samples, EGFR mutations in 10.4% (n = 7) and v-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in 2.9% (n = 2). Identified chromosomal alterations were v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) duplication in 2.9% (n = 2).
Conclusions
The cytological sample types examined in this study proved to be suitable for molecular testing, in addition to conventional morphologic diagnosis, showing versatility and adaptability to different clinical contexts. Molecular testing on cytological samples is accurate and fast, representing a valid tool for molecular profiling of advanced NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University Hospital of Salerno, Salerno, Italy.
- Department of Medicine and Surgery, University of Salerno, Salerno, Italy.
- Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona,", Salerno, Italy.
- Oncology Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Zitieren
APA
Maffei, E., Ciaparrone, C., D'Ardia, A., Giudice, V., Sabbatino, F., Giangrasso, A., Zeppa, P., & Caputo, A. (2025). Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers. Acta Cytologica, 69(2), 191-201. https://doi.org/10.1159/000543739
Vancouver
Maffei E, Ciaparrone C, D'Ardia A, Giudice V, Sabbatino F, Giangrasso A, et al. Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers. Acta Cytologica. 2025;69(2):191-201. doi:10.1159/000543739
BibTeX
@article{Maffei2025,
author = {Maffei, Elisabetta and Ciaparrone, Chiara and D'Ardia, Angela and Giudice, Valentina and Sabbatino, Francesco and Giangrasso, Antonino and Zeppa, Pio and Caputo, Alessandro},
title = {Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers},
journal = {Acta Cytologica},
year = {2025},
volume = {69},
number = {2},
pages = {191--201},
doi = {10.1159/000543739}
}
EUVIMED